 | | PRD_000011 | | Name: | N8-Actinomycin D | | Formula: | C61 H85 N13 O16 | | Description: | ACTINOMYCIN D CONSISTS OF TWO PENTAMER
RINGS LINKED BY THE CHROMOPHORE (PXA)
THE CHROMOPHORE PXA IS A MODIFIED PXZ WITH
N REPLACING C-H IN POSITION 8 OF THE
PHENOXAZONE RING. | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000900 | | Name: | N-(benzylsulfonyl)-D-leucyl-N-(4-carbamimidoylbenzyl)-L-prolinamide | | Formula: | C26 H35 N5 O4 S | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000020 | | Name: | D-phenylalanyl-N-[(2S,3S)-6-{[amino(iminio)methyl]amino}-1-chloro-2-hydroxyhexan-3-yl]-L-prolinamide | | Formula: | C21 H34 Cl N6 O3 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000021 | | Name: | D-phenylalanyl-N-[(3S)-6-carbamimidamido-1-chloro-2-oxohexan-3-yl]-L-prolinamide | | Formula: | C21 H31 Cl N6 O3 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000102 | | Name: | CYCLIC HEXAPEPTIDE RR(NAL)(NAL)RF | | Formula: | C53 H70 N15 O6 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000103 | | Name: | CYCLIC HEXAPEPTIDE KKWWKF | | Formula: | C49 H68 N11 O6 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000104 | | Name: | CYCLIC HEXAPEPTIDE RRYYRF | | Formula: | C45 H66 N15 O8 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000910 | | Name: | B4Z inhibitor | | Formula: | C24 H44 N6 O6 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000105 | | Name: | CYCLIC HEXAPEPTIDE CYC-(RRWWRF) | | Formula: | C49 H68 N17 O6 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000911 | | Name: | C4Z inhibitor | | Formula: | C27 H42 N6 O6 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000106 | | Name: | BOC-(D-NLE-L-NLE)4-D-NLE(METHYL)-L-NLE-D-NLE-L-NLE METHYL ESTER | | Formula: | C79 H146 N12 O15 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000912 | | Name: | C6Z inhibitor | | Formula: | C34 H54 N8 O10 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000107 | | Name: | H-(L-TYR-D-TYR)4-LYS-OH | | Formula: | C78 H87 N10 O18 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000913 | | Name: | M4Z inhibitor | | Formula: | C24 H39 N7 O6 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000108 | | Name: | HCO-(D-NLE-L-NLE)3-D-MENLE-L-NLE-D-NLE-L-NLE-OME | | Formula: | C63 H116 N10 O12 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000109 | | Name: | BOC-L-NLE-(D-NLE-L-NLE)5-D-NLE(METHYL)-L-NLE-D-NLE-L-NLE METHYL ESTER | | Formula: | C96 H177 N15 O18 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000919 | | Name: | N-{(2R)-2-[2-(hydroxyamino)-2-oxoethyl]-4-methylpentanoyl}-3-methyl-L-valyl-N-(2-aminoethyl)-L-alaninamide | | Formula: | C19 H37 N5 O5 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000110 | | Name: | DLY-HGL-AGD-LHC-AGD-LHC-CUD-LYS | | Formula: | C60 H81 N34 O15 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000920 | | Name: | SAMAROSPORIN I | | Formula: | C77 H120 N16 O19 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000117 | | Name: | ARYLOMYCIN A2 | | Formula: | C42 H60 N6 O11 | | Description: | ARYLOMYCIN A2 IS A BIARYL-BRIDGED LIPOPEPTIDE. THE SCAFFOLD IS MADE OF TWO PARTS: (1) N-TERM EXOCYCLIC TRIPEPTIDE (2)
A TRICYCLIC PEPTIDE, WITH [3,3] BIARYL BOND BETWEEN RESIDUE 4 AND 6 AN ISO-C12 FATTY ACID IS LINKED TO RESIDUE 1. | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000921 | | Name: | Noxa BH3 peptide (cysteine-mediated cross-linked) | | Formula: | C106 H179 N33 O25 S2 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000142 | | Name: | Cyclosporin A | | Formula: | C62 H111 N11 O12 | | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI. | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000143 | | Name: | Cyclosporin D | | Formula: | C64 H115 N11 O12 S | | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI.
CYCLOSPORIN D IS A NATURAL ANALOG OF CYCLOSPORIN A,
OBTAINED FROM A DIFFERENT NUTRIENT BROTH AND
DIFFERS FROM CYCLOSPORIN IN RESIDUE 6 (ABA6VAL). | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000144 | | Name: | Cyclosporin C | | Formula: | C62 H111 N11 O13 | | Description: | CYCLOSPORIN C IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI.
CYCLOSPORIN C IS A NATURAL ANALOG OF CYCLOSPORIN A,
OBTAINED FROM A DIFFERENT NUTRIENT BROTH AND DIFFERS
FROM CYCLOSPORIN A IN RESIDUE 6 (ABA6THR). | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000150 | | Name: | GRAMICIDIN A | | Formula: | C99 H140 N20 O17 | | Description: | GRAMICIDIN A IS A HEXADECAMERIC HELICAL PEPTIDE
WITH ALTERNATING D,L CHARACTERISTICS.
THE N-TERM IS FORMYLATED (RESIDUE 0).
THE C-TERM IS CAPPED WITH ETHANOLAMINE (RESIDUE 16). | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
